Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future

Bibliographic Details
Main Authors:	Lynna Alnimer, Mazen Noureddin
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2023-04-01
Series:	Clinical and Molecular Hepatology
Subjects:	steatosis fibrosis noninvasive imaging nafld
Online Access:	http://e-cmh.org/upload/pdf/cmh-2023-0104.pdf

Similar Items

Noninvasive assessment of nonalcoholic fatty liver disease
by: Gajanan A Rodge, et al.
Published: (2021-01-01)

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Sebastian Zenovia, et al.
Published: (2021-04-01)

Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis
by: Hossein Rafiei, et al.
Published: (2023-10-01)

Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
by: Vera Francisco, et al.
Published: (2022-08-01)

Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Wesam Bahitham, et al.
Published: (2024-02-01)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
by: Asako Nogami, et al.
Published: (2023-02-01)

Association of nutrient intake with non-alcoholic fatty liver disease and liver steatosis in adult Indian population – A case control study
by: Swapna Chaturvedi, et al.
Published: (2023-06-01)

Cyanotoxins Increase Cytotoxicity and Promote Nonalcoholic Fatty Liver Disease Progression by Enhancing Cell Steatosis
by: Suryakant Niture, et al.
Published: (2023-06-01)

Evaluación de fibrosis en pacientes con enfermedad por hígado graso no alcohólico: adherencia a los algoritmos propuestos y barreras para cumplir con ellos
by: S. Marciano, et al.
Published: (2022-01-01)

Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver disease
by: Tarang Taghvaei, et al.
Published: (2023-12-01)

The steatosis-associated fibrosis estimator (SAFE) outperformed the FIB-4 score in screening the population for liver disease
by: Mingkai Li, et al.
Published: (2024-09-01)

Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary
by: Rosanna Villani, et al.
Published: (2023-03-01)

Diagnostic Performance of Ultrasound in Detecting Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease Considering MRI Proton Density Fat Fraction as the Reference Standard
by: Ankita Aggarwal, et al.
Published: (2024-01-01)

Non-alcoholic fatty liver disease (NAFLD) is associated with dynamic changes in DNA hydroxymethylation
by: Marcus J. Lyall, et al.
Published: (2020-02-01)

The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and hepatic steatosis and liver fibrosis among US adults based on NHANES
by: Baoyu Li, et al.
Published: (2025-02-01)

Correlation between ZJU index and hepatic steatosis and liver fibrosis in American adults with NAFLD
by: Shuang Luo, et al.
Published: (2024-08-01)

The essential effect of mTORC1-dependent lipophagy in non-alcoholic fatty liver disease
by: Xiangyun Tan, et al.
Published: (2023-03-01)

Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease
by: Jincheng Wang, et al.
Published: (2022-12-01)

The Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases
by: Hendy OM, et al.
Published: (2019-12-01)

Association between weight-adjusted-waist index with hepatic steatosis and liver fibrosis: a nationally representative cross-sectional study from NHANES 2017 to 2020
by: Yun Shen, et al.
Published: (2023-05-01)

Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia
by: Giuseppe Mandraffino, et al.
Published: (2022-07-01)

Association between serum cotinine and hepatic steatosis and liver fibrosis in adolescent: a population-based study in the United States
by: Dan She, et al.
Published: (2024-05-01)

Analysis of the mediating role of BMI in associations of different folate forms with hepatic steatosis and liver fibrosis in adolescents in the USA: results from the NHANES 2017-2018
by: Jingli Wen, et al.
Published: (2023-12-01)

Ultrasound Methods for the Assessment of Liver Steatosis: A Critical Appraisal
by: Dorotea Bozic, et al.
Published: (2022-09-01)

Clinical-radiomic analysis for non-invasive prediction of liver steatosis on non-contrast CT: A pilot study
by: Shengnan Tang, et al.
Published: (2023-03-01)

Non-alcoholic fatty liver disease—A pilot study investigating early inflammatory and fibrotic biomarkers of NAFLD with alcoholic liver disease
by: Joanne Watt, et al.
Published: (2022-12-01)

Association of physical activity and fine motor performance in individuals with type 2 diabetes mellitus and/or non-alcoholic fatty liver disease
by: Ali A. Weinstein, et al.
Published: (2023-12-01)

Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update
by: Laura Giuseppina Di Pasqua, et al.
Published: (2022-01-01)

Study of Prevalence of Non-Alcoholic Fatty Liver Disease in Hypothyroidism and Possible Association of Hypothyroidism with NAFLD Fibrosis Score in Odisha
by: Siba Prasad Dalai, et al.
Published: (2024-07-01)

Study of Prevalence of Non-Alcoholic Fatty Liver Disease in Hypothyroidism and Possible Association of Hypothyroidism with NAFLD Fibrosis Score in Odisha
by: Siba Prasad Dalai, et al.
Published: (2024-07-01)

Relationship between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients
by: Alihan Oral, et al.
Published: (2019-09-01)

The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers
by: Zahra Safari, et al.
Published: (2023-05-01)

Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study
by: Abo-Amer YEE, et al.
Published: (2020-03-01)

Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease
by: Samradhi Singh, et al.
Published: (2024-09-01)

Screening strategy for non-alcoholic fatty liver disease
by: Saisai Zhang, et al.
Published: (2023-02-01)

Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis
by: Fuji Yang, et al.
Published: (2023-07-01)

Association of hepatic steatosis and liver fibrosis with chronic obstructive pulmonary disease among adults
by: Dayang Zheng, et al.
Published: (2024-05-01)

β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
by: Janet Sánchez-Quevedo, et al.
Published: (2022-09-01)

Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease
by: Marium Ahmed, et al.
Published: (2024-04-01)

The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
by: Ivana Mikolasevic, et al.
Published: (2022-02-01)